Waxman Quoted on Health Care Under Obama Administration

27 January 2010 IRB Advisor News

Foley Partner Mark Waxman was quoted in an article titled “What impact will Obama administration have on human subjects research?” in the February 1, 2010 issue of IRB Advisor. Waxman discusses proposed changes to the health care industry under the Obama administration, stating that a possible change would be the lifting of the ban on federal funding of stem cell research and an increase in the number of stem cell trials. He adds that two bills to watch are the Fair Access to Clinical Trials act, which would strengthen a national data base of clinical trials information, and the Physician Payments Sunshine Act of 2008, which calls for transparency in physician relationships with pharmaceutical and device companies.

People

Related Services

Insights

European Data Protection Board Issues Recommendations for Exports of Personal Data From the European Economic Area
01 December 2020
Privacy, Cybersecurity & Technology Law Perspectives
Podcast Episode 24: Steve Cade, Partner
01 December 2020
Foley Career Perspectives
U.S. Companies Must Prepare to Pay Higher Wages for Specialty Occupation Foreign Workers
30 November 2020
Labor & Employment Law Perspectives
A Shield for Employers: State COVID-19 Indemnity Laws
30 November 2020
Coronavirus Resource Center:Back to Business
HCCA San Francisco Regional Conference
04 December 2020
Virtual Conference
Webinar: Massachusetts Paid Family and Medical Leave 2021
02 December 2020
Webinar
CTeL Digital Health Summit 2020
01-04 December 2020
Virtual Conference
Virtual CLE Week
Every Tuesday & Thursday from December 1 - 17 2020
Webinar